UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009362 |
|---|---|
| Receipt number | R000011002 |
| Scientific Title | Phase I trial of combined chemotherapy of bevacizumab, panitumumab and irinotecan as 3rd-line chemotherapy in chmotherapy-refractory metastatic colorectal cancer. |
| Date of disclosure of the study information | 2012/11/26 |
| Last modified on | 2016/11/22 18:24:21 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/11/19 20:47:46 | ||
| 2 | Update | 2014/02/07 12:26:38 | Email Email1 |
|
| 3 | Update | 2016/11/22 18:24:21 | Recruitment status Publication of results |
